Total raised
$3.0M
Last: Undisclosed 2023-07
Stage
Seed
Founded
2016
Headcount
17
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
BioChange specializes in tissue regeneration technology and is the developer of CellFoam, an injectable scaffold that stimulates tissue repair and remodeling at the site of injection. Based on natural biomaterials designed for implantation using a minimally invasive procedure, the scaffold mimics the healthy extra-cellular matrix and triggers the body to repair itself.
Funding history · 2 rounds · $3.0M total
2023-07
Undisclosed
$3.0M
2021-10
Equity crowdfunding
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is BioChange's core technology?
- BioChange specializes in tissue regeneration technology and developed CellFoam, an injectable scaffold made from natural biomaterials that stimulates tissue repair and remodeling.
- When was BioChange founded and where is it headquartered?
- BioChange was founded in June 2016 and is headquartered in Yokne'am Illit, Israel.
- What was BioChange's most recent funding round?
- In July 2023, BioChange raised an undisclosed round of $3,000,000 from quadraScope.
- What was BioChange's first recorded funding event?
- In October 2021, BioChange completed an equity crowdfunding round with ExitValley.
- What grant did BioChange receive in 2017?
- In August 2017, BioChange received a $50,000 grant from the IIA (Israel Innovation Authority).
- What is the current employee count for BioChange?
- BioChange currently has 17 employees.
- What is one of BioChange's products for gum repair?
- BioChange developed ReGum, a product that has shown success in reversing receding gums in dogs, with human use anticipated.
- Who is a founder of BioChange?
- Ishay Attar is a founder of BioChange.
- What is the primary sector of BioChange?
- BioChange's primary sector is Health Tech & Life Sciences.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesCosmeticsHealthcareProvidersConsumersRecreational & LifestylePet Owners
Business model
B2B
Highlights
1 PatentsVerified
Tags
biodegradabledogspet-ownerstreatmentsbiotechnologytissue-regenerationdoctorsmedical-devicesminimally-invasiveregenerative-medicinemedical-technologiesveterinarydermatologyurology